Global Dementia Drugs Market Size was valued US$ 13,900.0 million in 2017 and is projected to reach up to USD XX.XX million by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 7.9% during the forecast period, i.e. 2017-2025.

Global Dementia Drugs Market Growth Opportunities (Revenue, Growth) By 2017-2025

Dementia is generally termed as declining mental ability, or memory loss after a certain age of an individual. It is not a specific disease, but occurs generally with the growing age of individual. Alzheimer’s diseases is the most common type of dementia which accounts for 70 to 80 percent of cases of dementia. Dementia is characterized by impairment of memory, communication & language, reasoning and judgment, and visual impairment.

Market Dynamics

Dementia Drugs market is estimated to grow at a healthy CAGR of 7.9% from 2017-2025. The market is expected to grow at a faster pace during the forecast period.  The Dementia Drugs market is primarily driven the increasing number of population suffering Alzheimer’s. Similarly, rate of underdiagnoses is 10% in low- and middle-income economies. This is expected to propel growth of the dementia drugs market. As of 2011, there were no standard guidelines for diagnosis of disease.

Furthermore, the dementia drugs market include the large number of drugs in the pipeline, which are expected to enter into the market by 2020-2022. According to the study published by Translational Research and Clinical Intervention, is recorded that 105 new drugs in pipeline, out of which 25 are in phase one, 52 in phase two and 28 are in phase three which will also fuel the market growth during the forecast period.

Segment Analysis 

Based on the drug type, Monoamine Oxidase Inhibitors (MAOI), Cholinesterase Inhibitors, Glutamate Inhibitors and Others. Monoamine Oxidase Inhibitors segment is anticipated to be the fastest growing drug class during the forecast period, due to their less toxic nature and high efficacy in aiding patients with extended life span.

On the basis of distribution channel, the in dementia drugs market size is categorized as offline channel, and online channel. The offline stores includes retail and hospital pharmacies are expected to hold the major revenue share market during the forecast period, owing to the increased regulations of major drug evaluation regulatory bodies such as the U.S. Food and Drug Administration (FDA).

Regional Analysis

Asia Pacific to hold the largest market share in this industry globally. The region to dominate the market growth in the coming years owning to the increasing number of geriatric population in the countries namely Japan, and India. In 2015, Japan’s Ministry of Health, Labour and Welfare Association, announced the launch of ‘New Orange Plan’, which aimed at early detection of dementia symptoms, development of novel drug, and increased medical facilities for patients suffering from the disease.

Global Dementia Drugs Market Size, Share Analysis By Region 2017

North America is expected to favor the growing Dementia Drugs market owning to the rising incidences of dementia, and increasing clinical study on developing drugs for dementia treatment, coupled with favorable reimbursement policies. Middle East and Africa market gaining attraction of the investment for the companies for more scope in the regions and expected to rise healthy growth over the forecast period.

Global Dementia Drugs Market Study Objective

1. To forecast the market size of dementia drugs market, along with describing and defining the market, in terms of volume and revenue.

2.Market analysis and forecast of dementia drugs market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of dementia drugs market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of dementia drugs market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the dementia drugs market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Bottom-up and top-down are two main approaches that were taken into account to anticipate and validate the market size of dementia drugs market, and to reach the anticipated market size of several dependent submarkets. The research and study involved massive utilization of secondary data sources, several directories, private and government websites, and authentic databases, to collect or gather market-oriented as well as technical information for the study of dementia drugs market commercially.

Key Players

Major players operating in global Dementia Drugs market include Janssen Pharmaceuticals, Inc., Eisai, Inc., Forest Laboratories, Inc., Biogen Pharmaceuticals, Sanofi S.A., F. Hoffmann-La Roche, Merck & Co., Inc.., Eli Lilly and Company, AstraZeneca GmbH Valeant Pharmaceutical International, Pfizer Inc., Novartis AG, and Teva Pharmaceuticals Industries Ltd.

Global Dementia Drugs Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast.

The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.